Gel Coat Biomaterials exhibited at BioJapan and Japan Healthcare Venture Summit 2025, showcasing hydrogel-based enzyme stabilization and bioprocess optimization technologies, as well as zwitterionic hydrogel applications for biomolecule protection and medical technology.
The company exhibited at BIO International Convention 2026 in San Diego, introducing its hydrogel-based biomolecule stabilization and surface modification technologies.
Shin Yoshida will present on functionalizing biomaterials using zwitterionic hydrogels at The Science Research Committee for Water and Future Living on November 17, 2025.
Shin Yoshida, President & CEO of Gel Coat Biomaterials, presented on biotech manufacturing services at a Japan Bioindustry Association webinar on October 1, 2024.
Gel Coat Biomaterials, based in Tokyo’s Bunkyo Ward, provides biomolecule stabilization technology using biocompatible ameba hydrogels, founded on patented research from Tokyo University’s Graduate School of Engineering.